ACE and COVID-19: It is also proposed that as β-adrenergic receptors regulate the level of renin, which ultimately regulate angiotensin-converting enzyme (ACE), the receptor for the entry of the SARS-CoV2 virus, so it is hypothesized that blocking beta-adrenergic receptors may have a beneficial role in treating COVID19 patients (Vasanthakumar, 2020).